Clinical efficacy of the smartplug (TM) in the treatment of primary Sjogren's syndrome with keratoconjunctivitis SICCA: one-year follow-up study
dc.contributor.author | Egrilmez, Sait | |
dc.contributor.author | Aslan, Fatih | |
dc.contributor.author | Karabulut, Gonca | |
dc.contributor.author | Kabasakal, Yasemin | |
dc.contributor.author | Yagci, Ayse | |
dc.date.accessioned | 2019-10-27T21:35:18Z | |
dc.date.available | 2019-10-27T21:35:18Z | |
dc.date.issued | 2011 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | To evaluate the efficacy of a thermo-sensitive punctum plug, (SmartPlug (TM)) in Primary Sjogren's Syndrome (pSS) patients with dry eyes, whose symptoms persist despite preservative-free artificial tear treatment. In this study, 22 Primary Sjogren's Syndrome (pSS), as defined by American-European Consensus Group Classification Criteria. All patients being followed up by Ege University Departments of Rheumatology and Ophthalmology. The patients had positive Schirmer test results (< 5 mm without anesthesia). SmartPlug (TM) (Medennium, Irvine, California, USA) was inserted into the inferior lacrimal canaliculi of both eyes. Visual acuity measurements, Schirmer I test measurements, lissamine green staining scores, and tear-film breakup times (BUT) were noted before plug insertion and at the 1st, 6th, and 12th months following the procedure. Minimum follow-up period was 6 months for 19 patients and 12 months for 16 patients. Significant improvements were seen in the Schirmer I test scores (before insertion: 1.98 +/- A 2.67; 1st month: 5.68 +/- A 6.69; 6th month: 5.35 +/- A 5.38; 12th month 6.43 +/- A 5.14 P = 0.006), tear-film BUT in seconds (before insertion: 4.64 +/- A 3.7; 1st month: 5.80 +/- A 2.36; 6th month: 7.53 +/- A 2.92; 12th month 7.50 +/- A 2.52, P < 0.0001), respectively. Thermodynamic punctum plug insertion only in inferior canaliculus is a simple, effective, and comfortable option for treatment of severe aqueous tear deficiency that cannot be controlled using preservative-free tears. | en_US |
dc.identifier.doi | 10.1007/s00296-010-1527-x | en_US |
dc.identifier.endpage | 1570 | en_US |
dc.identifier.issn | 0172-8172 | |
dc.identifier.issue | 12 | en_US |
dc.identifier.pmid | 20490802 | en_US |
dc.identifier.startpage | 1567 | en_US |
dc.identifier.uri | https://doi.org/10.1007/s00296-010-1527-x | |
dc.identifier.uri | https://hdl.handle.net/11454/45828 | |
dc.identifier.volume | 31 | en_US |
dc.identifier.wos | WOS:000297345900006 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer Heidelberg | en_US |
dc.relation.ispartof | Rheumatology International | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Dry eye | en_US |
dc.subject | Sjogren syndrome | en_US |
dc.subject | Punctal plug | en_US |
dc.subject | Smartplug | en_US |
dc.subject | Keratoconjunctivitis sicca | en_US |
dc.title | Clinical efficacy of the smartplug (TM) in the treatment of primary Sjogren's syndrome with keratoconjunctivitis SICCA: one-year follow-up study | en_US |
dc.type | Article | en_US |